Effects of Warfarin, Aspirin and the Two Combined, on Mortality and Thromboembolic Morbidity after Myocardial Infarction: The WARIS-II (Warfarin-Aspirin Reinfarction Study) Design

Author： Hurlen Mette   Smith Pål   Arnesen Harald  

Publisher： Informa Healthcare

ISSN： 1401-7431

Source： Scandinavian Cardiovascular Journal, Vol.34, Iss.2, 2000-05, pp. : 168-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 4-12

Karger

Access to resources Recommend Favorite

Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?

By Donadini Marco   Douketis James  

Journal of Thrombosis and Thrombolysis, Vol. 29, Iss. 2, 2010-02 ,pp. : 208-213

Springer Publishing Company

Access to resources Recommend Favorite

High dose aspirin and left ventricular remodeling after myocardial infarction: Aspirin and myocardial infarction

By Adamek A.   Hu K.   Bayer B.   Wagner H.   Ertl G.   Bauersachs J.   Frantz Stefan  

Basic Research in Cardiology, Vol. 102, Iss. 4, 2007-07 ,pp. : 334-340

Springer Publishing Company

Access to resources Recommend Favorite

Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and Hypothesis

By  

Cerebrovascular Diseases, Vol. 9, Iss. 4, 1999-06 ,pp. : 215-217

Karger

Access to resources Recommend Favorite

Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis

By  

Neuroepidemiology, Vol. 22, Iss. 2, 2003-03 ,pp. : 106-117

Karger

Access to resources Recommend Favorite